VKTX Stock Performance, Insider Transaction and News

VKTX - Viking Therapeutics, Inc.

Market Cap	1.39B	P/E	-	EPS this Y	-9.90%	Ern Qtrly Grth	-
Income	-96.75M	Forward P/E	-13.64	EPS next Y	-51.00%	50D Avg Chg	-25.00%
Sales	-	PEG	-1.56	EPS past 5Y	-	200D Avg Chg	10.00%
Dividend	N/A	Price/Book	3.60	EPS next 5Y	40.00%	52W High Chg	-46.00%
Recommedations	1.50	Quick Ratio	37.55	Shares Outstanding	110.80M	52W Low Chg	449.00%
Insider Own	6.03%	ROA	-11.57%	Shares Float	104.78M	Beta	1.00
Inst Own	75.17%	ROE	-14.80%	Shares Shorted/Prior	15.91M/17.70M	Price	13.91
Gross Margin	-	Profit Margin	-	Avg. Volume	2,851,827	Target Price	113.55
Oper. Margin	-	Earnings Date	Oct 23	Volume	1,253,300	Change	-1.77%

Healthcare | Biotechnology | United States

About Viking Therapeutics, Inc.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

Viking Therapeutics, Inc. News

03:05 PM	Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade
08:30 AM	Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?
04:32 AM	Where Will Viking Therapeutics Be in 5 Years?
10/13/24	Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics
10/13/24	With 74% institutional ownership, Viking Therapeutics, Inc. (NASDAQ:VKTX) is a favorite amongst the big guns
10/12/24	The Ultimate Biotech Stock to Buy With $100 Right Now
10/10/24	Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market
10/10/24	Viking reports data from X-linked adrenoleukodystrophy trial
10/09/24	Viking Therapeutics Reveals Encouraging Data From Genetic Disorder Drug Study, Analyst Says Focus On Orphan Disease Broadens Viking's Potential Revenue Streams
10/09/24	Viking Therapeutics Announces Results from Phase 1b Clinical Trial of VK0214 in Patients with X-ALD
10/07/24	Viking Therapeutics, Inc. (VKTX): A Hot Stock to Buy Now
10/07/24	2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts
10/04/24	Viking Therapeutics, Inc. (VKTX) Rises Higher Than Market: Key Facts
10/04/24	As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
10/03/24	Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today
10/02/24	Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
09/30/24	Why Viking Therapeutics Stock Topped the Market Today
09/29/24	Is Viking Therapeutics Stock a Buy?
09/29/24	Is Viking Therapeutics, Inc. (VKTX) the Best Performing Long Term Stock in 2024?
09/28/24	Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics

VKTX Chatroom

bavariaron Posted - 2 hours ago

$VKTX https://www.globenewswire.com/news-release/2024/10/14/2962407/0/en/Ardena-Signs-Agreement-to-Expand-US-Footprint-with-the-Acquisition-of-Advanced-Drug-Product-Manufacturing-Facility-from-Catalent.html VKTX

NoFearHere Posted - 2 hours ago

$VKTX tic- tic

Maverick11 Posted - 2 hours ago

@roger169 Thank you - I appreciate that. OKLO been a great one. Will continue. $ASPI has the makings for something big… as you know I endeavor not to post lightly and really hammer home the names I believe in … $CANOF $ASPI near term. As you probably know I love $VKTX and $RKLB. Good luck my friend - you can follow me on X at @neilsbhatia as well where I post also.

dick_dasterdly Posted - 4 hours ago

$VKTX Our chart is starting to tighten up like a nun touring a whorehouse. Get ready to bend over bears.. After the Nun.. it's your turn.

Theflash88 Posted - 4 hours ago

$VKTX Sold 1000 to scalp! Didn’t get back in on time! Pls don’t announce a BO tomorrow morning.

swingingtech Posted - 4 hours ago

$VKTX $MOD $ETSY https://wallstreetwaves.com/noteworthy-monday-option-activity-vktx-mod-etsy/

BloodyPortfolio Posted - 4 hours ago

@biolover @Braverabbit she must heard from a little bird. A bio analyst would not make such a bold move against BP behemoth without reasonable doubt. I believe this downgrade is very meaningful to $vktx. SC will reclaim the spot lights again. Oral remains very attractive in less crowed space.

Stocks4thought Posted - 5 hours ago

$VYGR Should rip hard .40 cents ot $SLNO $RANI $VKTX

SNOT_BROTHER Posted - 5 hours ago

$VKTX Thinking I’ll order takeout tonight. I know BL prefers takeout…

vu_jade Posted - 5 hours ago

$VKTX Tuesday takeover …

Enthropy_22 Posted - 6 hours ago

$VKTX tight

TrustButVerifi Posted - 6 hours ago

$VKTX To all the fools here who keep Monday morning Q-backing: one morning, afternoon or evening this ticker will be triple digit in an instant and then u won't be trading this but throwing up in the toilet!